Stephen Gordon, Chief Financial Officer at TransMedics Group, Inc. (TMDX), sold 19,969 shares at $61.30 ($1.2M) on 2022-12-01, disclosed to the SEC on 2022-12-05.
Open-market sale of $1.2M TMDX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.30 | 9,969 | $611K | 49.9% |
| 2 | $61.30 | 9,969 | $611K | 49.9% |
| 3 | $62.15 | 31 | $2K | 0.2% |
| Total | $61.30 avg | 19,969 | $1.2M | 100% |
| Filing → |
| TMDX | SELL | 2024-05-08 | $1.9M | — | Filing → |
| TMDX | SELL | 2024-04-02 | $1.1M | — | Filing → |
| TMDX | SELL | 2024-03-12 | $334K | — | Filing → |